denotes an abstract that is clinically relevant.
denotes that this is a recommended PHD Trainee Session.
denotes that this is a ticketed session.Sponsor: Alexion Pharmaceuticals, Inc
Program: Friday Satellite Symposia
Hematology Disease Topics & Pathways:
Research, Clinical Practice (Health Services and Quality), Diseases, Therapies, Adverse Events
Hematology Disease Topics & Pathways:
Research, Clinical Practice (Health Services and Quality), Diseases, Therapies, Adverse Events
Friday, December 8, 2023: 3:00 PM-6:00 PM
Marriott Grand Ballroom 2-4
(Marriott Marquis San Diego Marina)
Chair:
Ilene C. Weitz, MD, Keck School of Medicine of USC
Disclosures:
No relevant conflicts of interest to declare.
Speakers:
Vincent T. Ho, MD, Harvard Medical School
and
David J Kuter, MD, DPhil, Massachusetts General Hospital
Disclosures:
Ho: Alexion: Speakers Bureau; Orca Bio: Consultancy; Omeros: Research Funding; Jazz: Research Funding; CareDx: Research Funding; Alexion: Consultancy; Allovir: Consultancy; Omeros: Consultancy. Kuter: Alnylam, BioCryst, Novartis, Rigel, Sanofi (Principia), Takeda (Bioverativ), and UCB: Research Funding; AIRx, Alexion (Syntimmune), Alnylam, Alpine, Amgen, argenx, BioCryst, Bristol Myers Squibb (BMS), Caremark, Cellularity, Cellphire, Chugai, CRICO, Daiichi Sankyo, Dianthus, Electra Therapeutics, Fuji, Hemopure, Hengrui. Immunovant, Incyte, Inmagenebio: Consultancy; Rubius: Current equity holder in publicly-traded company; AIRx, Alexion (Syntimmune), Alnylam, Alpine, Amgen, Argenx, BioCryst, Bristol Myers Squibb (BMS), Caremark, Cellularity, Cellphire, Chugai, CRICO, Daiichi Sankyo, Dianthus, Electra Therapeutics, Fuji, Hemopure, Hengrui, Immunovant, Incyte, Inmagenebio, Ke: Honoraria; UpToDate: Patents & Royalties: UpToDate Chapters; Platelet Disorder Support Association: Membership on an entity's Board of Directors or advisory committees; Kezar, Kyowa-Kirin, Merck Sharp & Dohme: Honoraria; Kezar, Kyowa-Kirin, Merck Sharp Dohme, Momenta, Novartis, Nuvig, Pfizer, Platelet Biogenesis, Platelet Disorder Support Association, Protagonist, Rigel, Sanofi (Bioveratif), Sanofi (Principia), Sanofi (Genzyme), Sobi (Dova), Takeda, UCB, Up-To-Date, Zafge: Consultancy.
On Demand program will be available here January 8, 2024.
In this live, interactive program, expert faculty will present and discuss the most recent and relevant data and clinical advances as well as provide their expert perspectives around three rare, complex hematologic disorders marked by dysfunction of the complement cascade: atypical hemolytic uremic syndrome (aHUS), paroxysmal nocturnal hemoglobinuria (PNH), and hematopoietic stem cell transplantation-associated thrombotic microangiopathy (HSCT-TMA). The patient experience using vignettes will be highlighted throughout the event with an emphasis on optimizing clinical decision-making.
See more of: Friday Satellite Symposia